Cause-specific colostomy rates after radiotherapy for anal cancer: A danish multicentre cohort study

Journal of Clinical Oncology

Volumn 29, Issue 26, 2011, Pages 3535-3540

  Sunesen, Kåre G ^a,b   Nørgaard, Mette ^a   Lundby, Lilli ^a   Havsteen, Hanne ^c   Buntzen, Steen ^a   Thorlacius Ussing, Ole ^b   Laurberg, Srøen ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE;

ADJUVANT THERAPY; ADULT; AGED; ANUS CANCER; ARTICLE; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COLOSTOMY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RISK FACTOR; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; COHORT STUDIES; COLOSTOMY; COMBINED MODALITY THERAPY; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RISK FACTORS;

EID: 80053022616     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.1790     Document Type: Article

References (34)

1. Uronis HE, Bendell JC: Anal cancer: An overview. Oncologist 12:524-534, 2007 (Pubitemid 350012115)
2. Papillon J: Radiation therapy in the management of epidermoid carcinoma of the anal region. Dis Colon Rectum 17:181-187, 1974
3. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin: UKCCCR Anal Cancer Trial Working Party - UK Coordinating Committee on Cancer Research. Lancet 348:1049-1054, 1996
4. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539, 1996 (Pubitemid 26300120)
5. Bartelink H, Roelofsen F, Eschwege F, et al: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997 (Pubitemid 27209535)
6. Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 299:1914-1921, 2008 (Pubitemid 351574921)
7. Conroy T, Ducreux M, Lemanski C, et al: Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 trial. J Clin Oncol 27:176s, 2009 (suppl; abstr 4003)
8. James R, Wan S, Glynne-Jones R, et al: A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol 27:797s, 2009 (suppl; abstr LBA-4009)
9. Peiffert D, Bey P, Pernot M, et al: Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37:313-324, 1997 (Pubitemid 27138714)
10. Deniaud-Alexandre E, Touboul E, Tiret E, et al: Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56:1259-1273, 2003 (Pubitemid 36842877)
11. Chapet O, Gerard JP, Riche B, et al: Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63:1316-1324, 2005 (Pubitemid 41628024)
12. Grabenbauer GG, Kessler H, Matzel KE, et al: Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: Long-term results of 101 patients. Dis Colon Rectum 48:1742-1751, 2005 (Pubitemid 41243129)
13. Nilsson PJ, Svensson C, Goldman S, et al: Epidermoid anal cancer: A review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 61:92-102, 2005 (Pubitemid 40039110)
14. De Bree E, van RS, Dewit LG, et al: High risk of colostomy with primary radiotherapy for anal cancer. Ann Surg Oncol 14:100-108, 2007
15. Oehler-Jänne C, Seifert B, Lutolf UM, et al: Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy 6:218-226, 2007 (Pubitemid 47187802)
16. Widder J, Kastenberger R, Fercher E, et al: Radiation dose associated with local control in advanced anal cancer: Retrospective analysis of 129 patients. Radiother Oncol 87:367-375, 2008
17. Young SC, Solomon MJ, Hruby G, et al: Review of 120 anal cancer patients. Colorectal Dis 11:909-914, 2009
18. Olivatto LO, Cabral V, Rosa A, et al: Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: Long-term results. Int J Radiat Oncol Biol Phys 79:490-495, 2011
19. Ajani JA, Winter KA, Gunderson LL, et al: US intergroup anal carcinoma trial: Tumor diameter predicts for colostomy. J Clin Oncol 27:1116-1121, 2009
20. Vordermark D: Cause-specific colostomy rates after chemoradiotherapy for anal carcinoma: Cancer-related versus treatment-related colostomy. J Clin Oncol 27:3064, 2009
21. Pedersen CB, Gotzsche H, Moller JO, et al: The Danish Civil Registration System: A cohort of eight million persons. Dan Med Bull 53:441-449, 2006 (Pubitemid 44816920)
22. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry: History, content, quality and use. Dan Med Bull 44:535-539, 1997
23. Andersen TF, Madsen M, Jorgensen J, et al: The Danish National Hospital Register: A valuable source of data for modern health sciences. Dan Med Bull 46:263-268, 1999 (Pubitemid 29299976)
24. Greene FL, Page DL, Flemming ID, et al (eds): Anal canal, in AJCC Cancer Staging Manual (ed 6). New York, NY, Springer, 2002, pp 125-130
25. Scrucca L, Santucci A, Aversa F: Competing risk analysis using R: An easy guide for clinicians. Bone Marrow Transplant 40:381-387, 2007 (Pubitemid 47202424)
26. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
27. Scrucca L, Santucci A, Aversa F: Regression modeling of competing risk using R: An in depth guide for clinicians. Bone Marrow Transplant 45:1388-1395, 2010
28. Nguyen WD, Mitchell KM, Beck DE: Risk factors associated with requiring a stoma for the management of anal cancer. Dis Colon Rectum 47:843-846, 2004 (Pubitemid 38702603)
29. Allal AS, Mermillod B, Roth AD, et al: Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 39:1099-1105, 1997 (Pubitemid 27506163)
30. Ortholan C, Ramaioli A, Peiffert D, et al: Anal canal carcinoma: Early-stage tumors < or =10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 62:479-485, 2005 (Pubitemid 40704465)
31. Graf R, Tilly W, Hildebrandt B, et al: Local excision in combined modality treatment of anal carcinoma. Int J Radiat Oncol Biol Phys 57:S387, 2003 (suppl; abstr 2074)
32. Hu K, Minsky BD, Cohen AM, et al: 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol 70:71-77, 1999
33. Hatfield P, Cooper R, Sebag-Montefiore D: Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Int J Radiat Oncol Biol Phys 70:419-424, 2008
34. Cooper R, Mason M, Finan P, et al: Defunctioning stomas prior to chemoradiation for anal cancer are usually permanent. Colorectal Dis 10.1111/j.1463-1318.2010.02529.x 2010 [epub ahead of print on November 29, 2010]